Operating profit/loss (EBIT) of Sobi 2009-2023
In 2023, Sobi's operating profit stood at 4.07 billion Swedish kronor. Swedish biopharmaceutical company Sobi had a negative EBIT during the period from 2011 to 2014, but over the following years, it increased significantly, and in 2020 Sobi's operating profit was around 4.8 billion Swedish kronor, the highest amount so far. The company's full name is Swedish Orphan Biovitrum AB. Sobi is specialized on the treatment of rare diseases.